Metabolic Serum Biomarkers for the Prediction of Cancer: A Follow-Up of the Studies Conducted in the Swedish AMORIS Study

ecancermedicalscience - United Kingdom
doi 10.3332/ecancer.2015.555
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ecancer Global Foundation

Related search

Thyroid Cancer Risk in the Swedish AMORIS Study: The Role of Inflammatory Biomarkers in Serum

Oncotarget
Oncology
2017English

Inorganic Phosphate and the Risk of Cancer in the Swedish AMORIS Study

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

Serum Inflammatory Markers in Relation to Prostate Cancer Severity and Death in the Swedish AMORIS Study

International Journal of Cancer
Cancer ResearchOncology
2018English

Glucose and Lipoprotein Biomarkers and Breast Cancer Severity Using Data From the Swedish AMORIS Cohort

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Serum Biomarkers to Predict Risk of Testicular and Penile Cancer in AMORIS

ecancermedicalscience
Cancer ResearchOncology
2017English

Chronic Inflammation Markers Are Associated With Risk of Pancreatic Cancer in the Swedish AMORIS Cohort Study

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Serum Ferritin Levels and the Development of Metabolic Syndrome and Its Components: A 6.5-Year Follow-Up Study

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

Cancer Incidence in a Cohort of Swedish Sewage Workers: Extended Follow Up

Occupational and Environmental Medicine
EnvironmentalPublic HealthOccupational Health
1999English

A Proposed Model for Prediction of Survival Based on a Follow-Up Study in Unresectable Pancreatic Cancer

BMJ Open
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy